Who Paid My Doc
Teri Leishman
Clinical Nurse Specialist, Perioperative Grand Junction, CO Clinical Nurse Specialist
NPI 1700517794 CMS profile 11350706
2108 Monument Village Cir, Grand Junction, CO 81507
General payments
$290
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Teri Leishman of Grand Junction, CO is reported in the CMS Open Payments database as having received $290 across 4 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $154 | 2 | |
| 2024 | General | $137 | 2 |
Beside peers
- Teri Leishman
- Colorado median
- Middle half of Colorado
- National median
In program year 2025, general payments to Teri Leishman were reported at $154. Among 17,059 Colorado profiles paid that year, the median was $144 and the middle half received between $41 and $532.
Show as a table
| Year | Teri Leishman | Colorado median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $137 | $40–$561 | $163 |
| 2020 | $0 | $109 | $32–$371 | $114 |
| 2021 | $0 | $127 | $33–$475 | $132 |
| 2022 | $0 | $136 | $40–$504 | $149 |
| 2023 | $0 | $144 | $43–$511 | $160 |
| 2024 | $137 | $144 | $42–$500 | $164 |
| 2025 | $154 | $144 | $41–$532 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 52 billing codesPaid by Medicare
$2,871,332
Medicare patients
436
Services billed
310,100
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 69% | |
| Osteoporosis | 67% | |
| Ischemic heart disease | 37% | |
| Chronic kidney disease | 33% | |
| Depression | 29% | |
| Diabetes | 27% | |
| COPD | 22% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, denosumab, 1 mg J0897 | Office | 179 | 13,080 | $260,707 |
| Injection, lecanemab-irmb, 1 mg J0174 | Office | 32 | 141,680 | $148,523 |
| Injection, romosozumab-aqqg, 1 mg J3111 | Office | 27 | 14,910 | $126,602 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) J0129 | Office | 14 | 3,388 | $114,488 |
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) J0717 | Office | 14 | 25,200 | $90,937 |
| Injection, infliximab, excludes biosimilar, 10 mg J1745 | Office | 19 | 3,070 | $76,196 |
| Capsaicin 8% patch, per square centimeter J7336 | Office | 22 | 28,840 | $74,439 |
| Injection, inclisiran, 1 mg J1306 | Office | 11 | 3,408 | $32,255 |
| Injection, zoledronic acid, 1 mg J3489 | Office | 50 | 250 | $1,260 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Payments and prescribing
2 products · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| Qutenza |
|
$119 | — | 28,840 |
| CUVITRU |
|
$17 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
Records
4 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Nurse Specialist, Perioperative in Colorado
Related records
Clinical Nurse Specialist, Perioperative in Colorado
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Nurse Specialist, Perioperative
Everyone recorded under this specialty, nationwide.
Doctors in Colorado
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.